Timo Minssen

Background

About Timo Minssen

Law Professor & advisor, striving for sustainable & responsible innovation systems. Specialized in IP, data protection, tech-transfer, antitrust, regulation & ethics in health & life science innovation, incl. advanced medical computing, AI & quantum tech. Director, Center for Advanced Studies in Bioscience Innovation Law (CeBIL), UCPH. LML research affiliate at Cambridge University. Senior Consultant at X officio law firm, WHO/WIPO/EU advisor, governments & private sector. 7 books, 200+ publications in law, business & science outlets, incl. Science, Harvard Business Review, JAMA, NEJM Catalyst, Nature Genetics, Nature Biotech, Nature Electronics, Nature Digital Medicine, Lancet Digital Health & PLoS. PI of research projects with Harvard Law School, Harvard Medical School/MIT, Universities of Cambridge, DTU & Michigan. Ger. Staatsexamen & Dipl. Jur.(Göttingen). Life science & IP-related LL.D, LL.Lic. LL.M. & M.I.C.L.(Lund & Uppsala). Experience fr. law firms & life science SMEs, the European Patent Office & Courts (Ref. jur.). Visit. Prof./stipendiat/fellow at TUM, Universities of Cambridge, Oxford, Harvard & Chicago-Kent Law School, Max Planck Inst. f. Innovation & Competition, Pufendorf Institute f. Adv. Studies. Appointments: Founding Dir. of CeBIL LLM Affiliate, Cambridge University TUM Global Visiting Professor Sen. Advisor, X-Officio Advokat AB Advisory Board, MIPLC (Max Planck/TUM/GWU/UNA) Advisory Board, Digital home project, Harvard Law School Scientific Advisor, Oslo Medicines Initiative WHO Committee Member, Digital Health Chair, International Network of AMR Social Science,(INAMRSS), Global AMR R&D Hub PI & grant holder: Novo Nordisk Foundation Research Programme in Biomedical Innovation Law (35 + 50 mill DKK) CoPI, CLASSICA, EU Horizon Grant, AI-assisted surgery IPAB Member, Chr. Hansen A/S Board member Nordic Permed PI: AI@CARE - Laws & Ethics of Algorithmic Bias in Healthcare Member, Z-Initiative SAB, Influenz-er: Rethinking Pandemic Preparedness & Response EU Digital Health advisor Member, Genetic Discrimination Observatory Advisor, Copenhagen Economics' EU Commission study on “the economic impact of SPCs, pharma incentives & rewards" SCM,"Rechtsschutz biologischer Innovationen & Erfindungen", Max Planck Institute f. Innovation & Competition SCM, Danish Association f. the Protection of Industrial Property SCM, Danish Life Science Law Association (LifeScienceLaw.DK) SAB member, Copenhagen Centre f. Regulatory Sciences (CORS) Legal member, CPH Health Science Partners CAG.